Refine by:
-
Factors Associated with Availability of Mobile Crisis Services
Mobile crisis services are an important part of the mental health continuum of care, but access to these services varies. Analyzing data from a 2022 national survey of U.S. mental health treatment facilities, researchers found that more than 20% of facilities offered mobile crisis services.
-
Using Digital Mental Health Tools in Populations with Serious Mental Illness
Researchers conducted a review of existing research to understand factors that help or hurt engagement with digital mental health interventions by individuals with schizophrenia spectrum conditions or bipolar disorder and clinical staff.
-
Letter to Congressional Leadership on Research and Treatment Innovation and Health Coverage
Letter calling on Congress to pass the Ensuring Excellence in Mental Health Act (H.R. 8543/S. 2993) as a standalone bill or as part of any end of year legislative package. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter encouraging Congress to support the funding level proposed by the Senate Appropriations Committee for two NIH programs, the BRAIN Initiative and the All of Us Research Program, which would continue to make revolutionary advances that can improve brain and overall health outcomes. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter urging Congress to finalize the Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) spending bill by the end of the calendar year with a robust investment in the NIH. -
Letter to Congressional Leadership on Research and Innovation
Letter to House and Senate committee leaders expressing strong support for the COMPLETE Care Act (HR 5819/S. 1378) legislation, which would help clinicians adopt integrated behavioral health care delivery models. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter requesting that Congress include the $5 million for the FDA’s Neurology Drug Program, as proposed by the Senate Appropriations Committee. -
Study Finds Rates of Anxiety and Depression Still Higher Compared to Pre-COVID
Researchers compared rates of anxiety and depression among U.S. adults before, during, and after the pandemic using baseline data from the National Health Interview Survey and COVID-era data from the CDC Household Pulse Survey.
-
Learning More About Clinical Experiences Related to Schizophrenia
The U.S. Mental and Substance Use Disorders Prevalence Study (MDPS) was a landmark research effort designed to provide updated prevalence estimates for mental health conditions – including schizophrenia spectrum conditions – in U.S. adults. In this study, researchers used MDPS data to better understand characteristics associated with schizophrenia spectrum conditions.
-
Letter to CMS on Research and Treatment Innovation and Medicare
Letter to CMS Administrator Brooks-LaSure in support of the Centers for Medicare and Medicaid Services’ (CMS) proposal to cover digital mental health treatment in the Calendar Year 2025 Medicare Physician Fee Schedule (CY2025 PFS) proposed rule.